Table 2.
Univariate analysis between chemosensory and clinical and neuropsychiatric morbidity, only significant associations
Referred chemosensory symptoms (prevalence) | Independent variable | p value | Bonferroni adjusted p value |
---|---|---|---|
Parosmia (9%) | MCS | 0.001 | 0.004 |
Boston | 0.017 | 0.087 | |
ASQ | 0.024 | 0.120 | |
Anxiety Disorders | 0.037 | 0.185 | |
CMD | 0.056 | 0.280 | |
Moderate and severe current olfactory deficit (18%) | COVID-19 olfactory deficit | 0.000 | 0.000 |
TMT-A | 0.008 | 0.033 | |
Digit-symbol | 0.009 | 0.037 | |
Word List Memory Task | 0.041 | 0.166 | |
Age | 0.092 | 0.367 | |
Moderate and severe current gustatory deficit (20%) | COVID-19 gustatory deficit | 0.000 | 0.000 |
Word List Memory Task | 0.010 | 0.020 | |
Moderate and severe current olfactory and gustatory deficit (11%) | COVID-19 olfactory and gustatory deficit | 0.000 | 0.000 |
Word List Memory Task | 0.002 | 0.020 | |
Digit-symbol | 0.006 | 0.057 | |
TMT-A | 0.013 | 0.126 | |
Verbal Fluency | 0.015 | 0.155 | |
Age | 0.020 | 0.201 | |
Mixed Anxiety/Depressive Disorder | 0.040 | 0.397 | |
Word list recall | 0.053 | 0.532 | |
CMD | 0.058 | 0.577 | |
MCS | 0.079 | 0.794 |
MCS, Memory Complaint Scale; CMD, Common Mental Disorder; TMT-A, Trail Making Test – A